Express News | Shanghai Rightongene Says Co's Business Activities Remain Normal; Matter Will Not Have Adverse Impact on Co's Daily Operation

ReutersDec 5, 2024 09:24 ET

Shanghai Rightongene Biotechnology Co., Ltd. (SHSE:688217) Shares Fly 52% But Investors Aren't Buying For Growth

Simply Wall StOct 8, 2024 20:06 ET

Shanghai Rightongene Biotechnology Co., Ltd. (SHSE:688217) Not Doing Enough For Some Investors As Its Shares Slump 28%

Simply Wall StJul 23, 2024 18:00 ET

Shanghai Rightongene Biotechnology's (SHSE:688217) Soft Earnings Are Actually Better Than They Appear

Simply Wall StApr 25, 2024 18:53 ET

Retail Investors Invested in Shanghai Rightongene Biotechnology Co., Ltd. (SHSE:688217) Copped the Brunt of Last Week's CN¥387m Market Cap Decline

Simply Wall StFeb 5, 2024 18:38 ET

The Past One-year Earnings Decline for Shanghai Rightongene Biotechnology (SHSE:688217) Likely Explains Shareholders Long-term Losses

Simply Wall StFeb 2, 2023 22:27 ET